Autres langues Imexpharm Corporation

Actions

IMP

VN000000IMP0

Produits pharmaceutiques

Cours en clôture Ho Chi Minh S.E. Autres places de cotation 24/07/2026			Varia. 5j.	Varia. 1 janv.
35 000,00 ^VND	0,00%		-10,49%	-33,33%

20/07	Imexpharm Corporation publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI
02/07	Imexpharm Corporation annonce le versement d'un dividende en numéraire pour l'exercice 2025, payable le 21 juillet 2026	CI

Autres langues

20/07	Imexpharm Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
02/07	Imexpharm Corporation Announces Cash Dividend for the Year 2025, Payable on July 21, 2026
01/07	Imexpharm Corporation Announces Management and Committee Changes, Effective June 30, 2026
27/05	Imexpharm Corporation Announces Board Resignations
24/04	Imexpharm Corporation Approves Cash Dividend for the Year 2025; Provides Dividend Guidance for the Fiscal Year 2026
24/04	Imexpharm Corporation Provides Earnings Guidance for the Year 2026
20/04	Imexpharm Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026
09/03	Vietnam Securities Regulator Approves Livzon Subsidiary's Acquisition of Imexpharm
09/02	Imexpharm Corporation Announces the Approval of the Establishment of the Hai Phong Branch
20/01	Imexpharm Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025
20/01	Imexpharm Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025
08/01	Imexpharm Corporation Announces Establishing Cat Khanh Branch
07/01	Imexpharm Receives Approval to Expand Business Scope to Medical Equipment and Healthcare Wholesale Activities
31/12	Livzon Pharmaceutical Launches Tender Offer For Vietnam's Imexpharm, Raising Bid to 1.85 Billion Yuan
13/11	Imexpharm Corporation Announces Change in the 34 Business Registration Certificate
20/10/25	Imexpharm Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025
22/07/25	Imexpharm Corporation Announces Resignation of Nguyen an Duy as Chief Financial Officer, Effective July 31, 2025
22/07/25	Imexpharm Corporation Announces Resignation of Nguyen an Duy as Deputy General Director, Effective July 31, 2025
18/07/25	Imexpharm Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025
23/05/25	Livzon Pharmaceutical Group to Acquire 64.8% Stake in Vietnam's Imexpharm for 1.6 Billion Yuan
22/05/25	Livzon Pharma Says Subsidiary To Buy 64.8% Stake In Imexpharm Corporation
28/04/25	Imexpharm Corporation announces Annual dividend, payable on July 09, 2025
18/04/25	Imexpharm Corporation Reports Earnings Results for the First Quarter Ended March 31, 2025
20/01/25	Imexpharm Corporation Reports Earnings Results for the Full Year Ended December 31, 2024
29/11/24	Imexpharm Corporation Appoints Sung Min Woo as Chairperson of the Nomination and Compensation Committee Under the Board of Directors